Formulation & Delivery Series UK
Upperton will be exhibiting at the Formulation & Delivery Series UK in London from Wednesday 22nd to Thursday 23rd April, at stand 24.
We are looking forward to meeting both new and existing clients on our stand. So if you have an API which requires formulation development or clinical manufacture, please contact us to book an appointment or alternatively drop by our exhibition stand to talk to Upperton’s team
Recent News at Upperton
Upperton have been investing in new equipment to enhance our capabilities in manufacturing final dosage forms. Our current focus is in enhancing / increasing out put in our tabletting capabilities. In 2019 Upperton acquired a new cutting edge tablet press, Futorque X by KG-Pharma which can produce up to 130,000 tablets per hour or supporting DoE and research studies with minimal material.
The O Hara LC M5 coater was also purchased in 2019; film coating is a key process offering a wide range of drug delivery benefits including: taste/odour masking, stability protection, modification of release profiles, ease of administration and product identification. Upperton will follow these investments through the purchase of further tabletting equipment.
The new service UpperSolv™ was launched in late 2019. UpperSolv™ is a signposted pathway to rapid, tailored screening of small quantities of API, the manufacture of prototype formulations using a range of scalable enabling technologies and comparison of the biopharmaceutical performance via a PK assessment.
The Formulation & Delivery Series UK
The Formulation & Delivery Series UK, combines the 6th Annual Formulation & Drug Delivery Congress, 5th Annual Inhalation & Respiratory Drug Delivery Congress and Biomanufacturing Congress. With over 300 influencers, experts and researchers attending to learn about the latest updates in biopharmaceutical advancements shaping the future of drug product development.